FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2013021856> ?p ?o ?g. }

• W2013021856 endingPage "e112548" @default.
• W2013021856 startingPage "e112548" @default.
• W2013021856 abstract "The lymphatic vasculature plays a critical role in a number of disease conditions of increasing prevalence, such as autoimmune disorders, obesity, blood vascular diseases, and cancer metastases. Yet, unlike the blood vasculature, the tools available to interrogate the molecular basis of lymphatic dysfunction/disease have been lacking. More recently, investigators have reported that dysregulation of the PI3K pathway is involved in syndromic human diseases that involve abnormal lymphatic vasculatures, but there have been few compelling results that show the direct association of this molecular pathway with lymphatic dysfunction in humans. Using near-infrared fluorescence lymphatic imaging (NIRFLI) to phenotype and next generation sequencing (NGS) for unbiased genetic discovery in a family with non-syndromic lymphatic disease, we discovered a rare, novel mutation in INPPL1 that encodes the protein SHIP2, which is a negative regulator of the PI3K pathway, to be associated with lymphatic dysfunction in the family. In vitro interrogation shows that SHIP2 is directly associated with impairment of normal lymphatic endothelial cell (LEC) behavior and that SHIP2 associates with receptors that are associated in lymphedema, implicating its direct involvement in the lymphatic vasculature." @default.
• W2013021856 created "2016-06-24" @default.
• W2013021856 creator A5009756113 @default.
• W2013021856 creator A5021241849 @default.
• W2013021856 creator A5025182463 @default.
• W2013021856 creator A5029269080 @default.
• W2013021856 creator A5054283485 @default.
• W2013021856 creator A5062964311 @default.
• W2013021856 creator A5075852200 @default.
• W2013021856 creator A5077903398 @default.
• W2013021856 creator A5084413634 @default.
• W2013021856 creator A5086318602 @default.
• W2013021856 creator A5088469510 @default.
• W2013021856 date "2014-11-10" @default.
• W2013021856 modified "2023-10-14" @default.
• W2013021856 title "Evidence for SH2 Domain-Containing 5′-Inositol Phosphatase-2 (SHIP2) Contributing to a Lymphatic Dysfunction" @default.
• W2013021856 cites W1521411817 @default.
• W2013021856 cites W1600324901 @default.
• W2013021856 cites W1674259800 @default.
• W2013021856 cites W1919985275 @default.
• W2013021856 cites W1965513628 @default.
• W2013021856 cites W1972485191 @default.
• W2013021856 cites W1978369267 @default.
• W2013021856 cites W1991298929 @default.
• W2013021856 cites W1992496728 @default.
• W2013021856 cites W1993582702 @default.
• W2013021856 cites W1994634031 @default.
• W2013021856 cites W1994961642 @default.
• W2013021856 cites W1997248434 @default.
• W2013021856 cites W2004266914 @default.
• W2013021856 cites W2006642493 @default.
• W2013021856 cites W2012792646 @default.
• W2013021856 cites W2015220157 @default.
• W2013021856 cites W2016605186 @default.
• W2013021856 cites W2020180377 @default.
• W2013021856 cites W2020322997 @default.
• W2013021856 cites W2022399479 @default.
• W2013021856 cites W2022555480 @default.
• W2013021856 cites W2040016657 @default.
• W2013021856 cites W2041680298 @default.
• W2013021856 cites W2043074419 @default.
• W2013021856 cites W2045094761 @default.
• W2013021856 cites W2045204629 @default.
• W2013021856 cites W2048778908 @default.
• W2013021856 cites W2049007681 @default.
• W2013021856 cites W2055978688 @default.
• W2013021856 cites W2056194915 @default.
• W2013021856 cites W2066250513 @default.
• W2013021856 cites W2066862341 @default.
• W2013021856 cites W2067973732 @default.
• W2013021856 cites W2069124828 @default.
• W2013021856 cites W2071272976 @default.
• W2013021856 cites W2071959332 @default.
• W2013021856 cites W2079270029 @default.
• W2013021856 cites W2079572182 @default.
• W2013021856 cites W2084764067 @default.
• W2013021856 cites W2099703857 @default.
• W2013021856 cites W2111661868 @default.
• W2013021856 cites W2113461502 @default.
• W2013021856 cites W2113750989 @default.
• W2013021856 cites W2118182234 @default.
• W2013021856 cites W2125621940 @default.
• W2013021856 cites W2133661714 @default.
• W2013021856 cites W2136930833 @default.
• W2013021856 cites W2138802683 @default.
• W2013021856 cites W2142767975 @default.
• W2013021856 cites W2143158290 @default.
• W2013021856 cites W2157204277 @default.
• W2013021856 cites W2161383801 @default.
• W2013021856 cites W2164890061 @default.
• W2013021856 cites W2168142506 @default.
• W2013021856 cites W2170624487 @default.
• W2013021856 cites W2170957170 @default.
• W2013021856 doi "https://doi.org/10.1371/journal.pone.0112548" @default.
• W2013021856 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4226566" @default.
• W2013021856 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25383712" @default.
• W2013021856 hasPublicationYear "2014" @default.
• W2013021856 type Work @default.
• W2013021856 sameAs 2013021856 @default.
• W2013021856 citedByCount "12" @default.
• W2013021856 countsByYear W20130218562014 @default.
• W2013021856 countsByYear W20130218562016 @default.
• W2013021856 countsByYear W20130218562017 @default.
• W2013021856 countsByYear W20130218562019 @default.
• W2013021856 countsByYear W20130218562020 @default.
• W2013021856 countsByYear W20130218562021 @default.
• W2013021856 countsByYear W20130218562022 @default.
• W2013021856 countsByYear W20130218562023 @default.
• W2013021856 crossrefType "journal-article" @default.
• W2013021856 hasAuthorship W2013021856A5009756113 @default.
• W2013021856 hasAuthorship W2013021856A5021241849 @default.
• W2013021856 hasAuthorship W2013021856A5025182463 @default.
• W2013021856 hasAuthorship W2013021856A5029269080 @default.
• W2013021856 hasAuthorship W2013021856A5054283485 @default.
• W2013021856 hasAuthorship W2013021856A5062964311 @default.
• W2013021856 hasAuthorship W2013021856A5075852200 @default.
• W2013021856 hasAuthorship W2013021856A5077903398 @default.
• W2013021856 hasAuthorship W2013021856A5084413634 @default.

• next